Yues International Holdings Group Limited (1529) AI Stock Analysis

• Market Cap: HK$346.88M
• Dividend Yield: N/A
• Average Volume (3M): 167.60K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.16
• Revenue Growth: 106.55%
• EPS Growth: 63.20%
• Country: HK
• Employees: 640
• Sector: Industrials
• Sector Strength: 72
• Industry: Integrated Freight & Logistics
• EPS (TTM): >-0.01
• Shares Outstanding: 667,080,000
• 10 Day Avg. Volume: 316,200
• 30 Day Avg. Volume: 167,600
• PEG Ratio: >-0.01
• Price to Book (P/B): 0.22
• Price to Sales (P/S): 0.11
• P/FCF Ratio: -0.65
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 49 Neutral
• Price Target: HK$0.53 ▲(5.40% Upside)

The overall stock score is primarily impacted by significant financial instability, with ongoing losses and negative cash flows being major concerns. While technical analysis indicates some positive momentum, the poor valuation metrics and lack of earnings further weigh down the score. The absence of earnings call data and corporate events means these factors do not influence the score.

Positive Factors

Diversified Revenue Streams

The company's diversified revenue streams across trading, logistics, and financial services provide resilience against sector-specific downturns.

Strategic Partnerships

Partnerships enhance competitive pricing and service reliability, strengthening market position and supporting long-term growth.

Revenue Growth

Significant revenue growth indicates strong market demand and effective business strategies, supporting future expansion.

Negative Factors

Financial Instability

Ongoing financial instability due to losses and negative cash flows threatens long-term viability and limits investment capacity.

Rising Leverage

Increased leverage raises financial risk, potentially impacting creditworthiness and limiting future borrowing capacity.

Negative Cash Flow

Negative cash flow challenges liquidity, hindering the ability to fund operations and invest in growth opportunities.

Yues International Holdings Group Limited Business Overview & Revenue Model

Company Description

Yues International Holdings Group Limited (1529) is a diversified investment holding company based in Hong Kong. The company primarily operates in the sectors of trading and logistics, focusing on the import and export of various products, including consumer goods and electronics. Yues International also engages in financial services, providing investment solutions and asset management for its clients, thereby enhancing its portfolio across different industries.

How the Company Makes Money

Yues International generates revenue through multiple streams, primarily from its trading activities where it imports and exports goods, earning profit margins on sales. The company also derives income from its logistics services, which include warehousing and distribution, charging clients for storage and transportation solutions. Additionally, its financial services arm contributes to revenue by providing investment management and advisory services, which typically involve management fees based on assets under management. Strategic partnerships with suppliers and logistics firms further bolster its revenue by ensuring competitive pricing and reliable service delivery.

Yues International Holdings Group Limited Financial Statement Overview

Summary

Yues International Holdings Group Limited is facing financial challenges across its income statement, balance sheet, and cash flow statement. The company has shown a volatile revenue trajectory with a recent decline in gross profit and persistent net losses. The balance sheet shows moderate stability but with increased leverage, and the cash flow statement reveals declining operating cash flows and negative free cash flows.

Income Statement

The company has shown a volatile revenue trajectory with a recent decline in gross profit and persistent net losses. The gross profit margin has decreased significantly from previous years, indicating challenges in maintaining operational efficiency. The net profit margin remains negative, reflecting ongoing profitability issues. Despite past periods of growth, the recent decline is concerning.

Balance Sheet

The balance sheet shows moderate stability with a reasonable equity base. However, the debt-to-equity ratio has increased, indicating higher leverage which could pose risks if not managed properly. The return on equity is negative due to net losses, impacting shareholder value negatively. The equity ratio remains relatively stable, providing some financial cushion.

Cash Flow

The cash flow statement reveals a challenging situation with declining operating cash flows and negative free cash flows in recent years. The inability to generate positive free cash flow consistently is a major concern, impacting the company's liquidity position. The lack of operating cash flow to net income ratio highlights inefficiencies in converting profits into cash.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	347.17M	256.21M	133.88M	179.48M	211.78M	185.20M
Gross Profit	38.37M	26.52M	-21.96M	17.70M	19.03M	44.87M
EBITDA	-11.03M	-24.09M	-26.83M	4.23M	-7.55M	30.92M
Net Income	-16.43M	-24.71M	-34.43M	-170.00K	-17.10M	2.46M
Balance Sheet
Total Assets	276.07M	256.83M	282.83M	179.21M	184.55M	228.03M
Cash, Cash Equivalents and Short-Term Investments	134.76M	59.72M	78.03M	55.53M	108.16M	74.97M
Total Debt	6.98M	66.07M	78.09M	7.59M	9.62M	61.64M
Total Liabilities	86.05M	123.41M	139.02M	35.20M	53.92M	93.79M
Stockholders Equity	187.99M	129.94M	138.46M	144.01M	130.63M	134.24M
Cash Flow
Free Cash Flow	13.26M	-43.13M	-34.36M	438.00K	6.16M	12.92M
Operating Cash Flow	14.54M	-31.50M	-33.82M	3.39M	6.46M	16.70M
Investing Cash Flow	-24.82M	1.30M	27.81M	-24.33M	-5.54M	-2.67M
Financing Cash Flow	50.85M	816.00K	29.04M	8.56M	-7.49M	-9.43M

Yues International Holdings Group Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.50
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1529, the sentiment is Positive. The current price of 0.5 is above the 20-day moving average (MA) of 0.49, above the 50-day MA of 0.49, and above the 200-day MA of 0.37, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 52.39 is Neutral, neither overbought nor oversold. The STOCH value of 69.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1529.

Yues International Holdings Group Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
1732	53 Neutral	HK$288.00M	-50.00	-2.51%	―	-1.40%	-128.66%
1737	53 Neutral	HK$92.00M	―	-16.66%	20.41%	-27.59%	-396.23%
1529	49 Neutral	HK$346.88M	―	-9.91%	―	106.55%	63.20%
6123	45 Neutral	HK$455.61M	―	-4.97%	2.19%	-35.13%	-11.52%
8489	45 Neutral	HK$42.60M	―	-25.91%	―	3.45%	-339.07%
8292	40 Underperform	HK$474.46M	―	-7.88%	―	9.79%	89.05%

Yues International Holdings Group Limited Corporate Events

Yues International Holdings Announces Board Meeting for Interim Results

Yues International Holdings Group Limited has announced a board meeting scheduled for August 28, 2025, to discuss and approve the interim financial results for the first half of 2025. The meeting will also consider the possibility of declaring an interim dividend, which could impact the company’s financial strategy and shareholder returns.

Yues International Expands Chinese Medicine Focus with Reallocated Funds

Yues International Holdings Group Limited has announced supplemental information regarding its 2024 Annual Report, focusing on its share option schemes. The New Share Option Scheme includes directors, employees, and service providers as eligible participants, aiming to support the company’s long-term growth. Additionally, the company is reallocating approximately HK$20 million of unutilized net proceeds to enhance its Chinese medicine business, with plans to fully utilize these funds by the end of 2026. This strategic move is expected to bolster the company’s operations and market positioning.

Yues International Redirects Proceeds to Chinese Medicine Business

Yues International Holdings Group Limited has announced a change in the use of proceeds from a recent share placement. Originally intended for the development of its Intelligent Logistics Services Business, the company has decided to reallocate the remaining HK$30 million to its Chinese Medicine Business and general working capital. This strategic shift aligns with the company’s recent expansion into pharmaceutical distribution, aiming to capitalize on market opportunities and enhance shareholder value without adversely affecting its existing operations.